Schonfeld Group Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Schonfeld Group Holdings’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,007	Closed	-$934K	–	319
2015 Q3	$934K	Buy	+2,007	New	+$1.08M	0.49%	41
2014 Q4	–	Sell	-1,200	Closed	-$433K	–	30
2014 Q3	$433K	Buy	+1,200	New	+$402K	1.29%	16
2013 Q4	–	Sell	-2,500	Closed	-$782K	–	396
2013 Q3	$782K	Buy	+2,500	New	+$658K	1.6%	11

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Schonfeld Group Holdings's REGN Position: Q4 2015 in Review

Schonfeld Group Holdings sold out of Regeneron Pharmaceuticals (REGN) in Q4 2015, closing a stake of 2,007 shares — an estimated $934K sold.

Schonfeld Group Holdings first reported a position in REGN in Q3 2013 and held it in 3 quarters. The position peaked at $934K in Q3 2015. 575 funds tracked by Wall St. Rank hold REGN as of Q4 2015.

Schonfeld Group Holdings reported no remaining Regeneron Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Schonfeld Group Holdings sold 2,007 Regeneron Pharmaceuticals shares in Q4 2015, an estimated $934K.
Schonfeld Group Holdings first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 3 quarters.
Schonfeld Group Holdings's Regeneron Pharmaceuticals position peaked at $934K in Q3 2015.
575 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.